Kanakion Mm (Phytomenadione)

Phytomenadione serves as a cofactor for the gamma‑carboxylation of clotting factors II, VII, IX and X, enabling these proteins to bind calcium and participate effectively in the coagulation cascade, thereby restoring normal clotting function.

The appropriate dose of Kanakion Mm is determined by the prescribing healthcare professional based on the patient’s clinical condition, route of administration, and laboratory monitoring. Dosage should never be self‑adjusted.

Safety data for phytomenadione in pregnancy and lactation are limited. Use only if clearly needed and prescribed by a qualified clinician, who will weigh potential benefits against any possible risks to the mother and infant.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Kanakion Mm provides phytomenadione in both intravenous and oral formats, offering flexibility for acute or maintenance therapy. Compared with synthetic vitamin K analogues, phytomenadione is a natural form with a well‑established safety profile, though clinical choice depends on specific patient needs and local guidelines.

Store Kanakion Mm at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain stability.

Kanakion Mm can be given intravenously for rapid correction of deficiency or orally for ongoing maintenance. Administration route and rate are determined by the treating physician based on the clinical scenario and patient response.

Serious risks include anaphylactic reactions, severe bleeding or thrombosis, hemolytic anemia, and acute renal failure. Prompt medical attention is required if any signs of these severe adverse events occur.

Kanakion Mm should be avoided in individuals with known hypersensitivity to phytomenadione or any formulation components, and used with caution in patients with severe liver disease, uncontrolled hypertension, or those receiving interacting anticoagulant therapies.